Aldren 70 Dosage & Drug Information

Indications/Uses

Treatment & prevention of osteoporosis in postmenopausal women. Treatment to increase bone mass in men w/ osteoporosis.

Dosage/Direction for Use

70 mg once wkly.

Administration

Should be taken on an empty stomach: Take at least 30 min before the 1st food/drink/medication of the day w/ a full glass of plain water & remain in sitting/upright position for at least 30 min. Swallow whole, do not chew/crush.

Contraindications

Hypersensitivity. Abnormalities of the esophagus which delay esophageal emptying eg, stricture or achalasia. Inability to stand or sit upright for at least 30 min. Hypocalcemia.

Special Precautions

Discontinue use if dysphagia, odynophagia, retrosternal pain or new or worsening heartburn develop. Patients w/ active upper GI problems eg, dysphagia, esophageal diseases, gastritis, duodenitis or ulcers. Correct hypocalcemia & treat other disturbances of mineral metabolism (eg, vit D deficiency) prior to initiating therapy. Renal insufficiency (CrCl <35 mL/min). Pregnancy & lactation. Childn.

Adverse Reactions

Abdominal pain, nausea, dyspepsia, constipation, diarrhea, flatulence, acid regurgitation, esophageal ulcer, vomiting, dysphagia, abdominal distension, gastritis, gastric ulcer, melena; musculoskeletal (bone, muscle or joint) pain, muscle cramps; headache, dizziness; taste perversion.

View ADR Reporting Link

Drug Interactions

Ca supplements, antacids; aspirin-containing products; NSAIDs; IV ranitidine.

MIMS Class

Agents Affecting Bone Metabolism

ATC Classification

M05BA04 - alendronic acid ; Belongs to the class of bisphosphonates. Used in the treatment of bone diseases.

Regulatory Classification

Rx

Presentation/Packing

Form

Aldren tab 70 mg

Packing/Price

4's (P225/tab)

Aldren 70

alendronic acid

Manufacturer:

Zydus Healthcare

Distributor:

Zydus Healthcare